期刊文献+
共找到9篇文章
< 1 >
每页显示 20 50 100
A Biochemical Study on Combined Treatment of Experimental Silicosis with Tetradrine-PVNO and Tetradrine-QOHP in Rats 被引量:1
1
作者 YU LAN ZOU CHANG-QI +2 位作者 LI YU-RUI QU LEI XING KANG-JI AND DU QING-CHENG (Institute of Occupational Medicine, Chinese Academy of Preventive Medicine, Beijing 100050, China) 《Biomedical and Environmental Sciences》 SCIE CAS CSCD 1995年第3期265-268,共4页
A better understanding is needed to explain the mechanism of therapeutic effect of combined use of tetradrine-PVNO and tetradrine-QOHP which play very important roles in treatment of silicosis. Blood prolidase (PLD), ... A better understanding is needed to explain the mechanism of therapeutic effect of combined use of tetradrine-PVNO and tetradrine-QOHP which play very important roles in treatment of silicosis. Blood prolidase (PLD), monoamine oxidase (MAO) and plasminogen (PLG) in silicotic rats after treatment with tetradrine-PVNO or tetradrine-QOHP were measured. The values obtained were compared with the untreated silicotic rats. It was found that the silicotic rats that received tetradrine-PVNO showed significant increase in PLD and decrease in PLG, but no significant change in MAO. The PLD in plasma of silicotic rats that received tetradrine-QOHP were elevated significantly, but PLG and MAO did not change appreciably. These findings suggest that the combined use of tetradrine-PVNO and tetradrine-QOHP can accelerate the degradation of collagen in silicotic rats 展开更多
关键词 PVN A Biochemical Study on Combined treatment of experimental Silicosis with Tetradrine-PVNO and Tetradrine-QOHP in Rats
下载PDF
Experimental Study on Treatment of SIV Infection by Zhongyan No. II In Monkeys
2
作者 关崇芬 卢耀增 吴小间 《Chinese Journal of Integrated Traditional and Western Medicine》 2003年第2期156-156,共1页
Objective: To investigate the curative effect of Zhongyan No. II (ZY II ) in treating SIVmac251 infection in macaques monkeys and evaluate the anti-viral effect of the drug as well as its protection on organism. Metho... Objective: To investigate the curative effect of Zhongyan No. II (ZY II ) in treating SIVmac251 infection in macaques monkeys and evaluate the anti-viral effect of the drug as well as its protection on organism. Methods: Using SIVmac251 infected monkey model to detect the plasma SIVP 27 antigen level by viral isolation and ELISA; determine the T-lymphocyte subsets CD4 and CD8 by indirect immunofluorescence and flow cytometry, and investigate the serum content of neopterin and B2-mi-croglobulin B2-MG)by ELISA. The pathological examination was conducted as well. Results: ZY II 展开更多
关键词 SIV II In Monkeys experimental Study on treatment of SIV Infection by Zhongyan No ELISA WELL as in of by
下载PDF
Local immunotherapy with interleukin - 2 delivered from biodegradable polymer microspheres combined with interstitial chemotherapy: a novel treatment for experimental malignant glioma.
3
作者 Rhines LD DiMeco F +4 位作者 Lawson HC Tyler BM Hanes J Olivi A Brem H 《中国神经肿瘤杂志》 2003年第2期81-81,共1页
OBJECTIVE:Local delivery of carmustine(BCNU)from biodegradablepolymers prolongs survival against experi-mental brain tumors.Moreover,paracrine administration of interleukin-2(IL-2)has been shown to elicit apotent anti... OBJECTIVE:Local delivery of carmustine(BCNU)from biodegradablepolymers prolongs survival against experi-mental brain tumors.Moreover,paracrine administration of interleukin-2(IL-2)has been shown to elicit apotent antitumor immune response and to improve survival in animal brain tumor models.We report the use of anovel polymeric microsphere delivery vehicle to release IL-2.We demonstrate both in vitro release of cytokinefrom the microspheres and histological evidence of the inflammatory response elicited by IL-2 released from themicrospheres in the rat brain.Thees microspheres are used to deliver IL-2,and biodegradable polymer wafers 展开更多
关键词 BCNU Local immunotherapy with interleukin from delivered from biodegradable polymer microspheres combined with interstitial chemotherapy a novel treatment for experimental malignant glioma for with
下载PDF
The experimental study on treatment of nitrate pollution in aeration zone by cultural microorganism
4
《Global Geology》 1998年第1期31-32,共2页
关键词 The experimental study on treatment of nitrate pollution in aeration zone by cultural microorganism
下载PDF
Experimental and clinical research of application of plasma cool sediment in treatment of Traumatic surface of deep degree burn
5
《中国输血杂志》 CAS CSCD 2001年第S1期398-,共1页
关键词 DEEP experimental and clinical research of application of plasma cool sediment in treatment of Traumatic surface of deep degree burn
下载PDF
EXPERIMENTAL STUDY ON ANTIATHEROSCLEROTIC TREATMENT BY PGE_2 COMBINED WITH VITAMINE AND ESTRADIOL
6
作者 邱近明 高玉霞 +1 位作者 范英昌 王晓燕 《Chinese Medical Journal》 SCIE CAS CSCD 1995年第1期33-36,共4页
The effects of single dose of PGE2 combined with vitamin E and with estradiol on experimental atherosclerosis were studied by means of morphological, ultrastructural, autoradiographic and several functional techniques... The effects of single dose of PGE2 combined with vitamin E and with estradiol on experimental atherosclerosis were studied by means of morphological, ultrastructural, autoradiographic and several functional techniques. The results showed that two combined treatment groups had more coordinative inhibition on aortic and coronary atherosclerotic lesions, as well as on platelet aggregation, smooth muscle cell proliferation and lipid peroxidation than that of single dose of PGE2. It was revealed that the coordinative mechanism might be closely related to the synergistic inhibitory function of above-metioned drugs on endothelial permeability, platelet aggregation, smooth muscle cell proliferation and lipid peroxidation. 展开更多
关键词 PGE Cd HE VS In experimental STUDY ON ANTIATHEROSCLEROTIC treatment BY PGE2 COMBINED WITH VITAMINE AND ESTRADIOL
原文传递
AN EXPERIMENTAL TRIAL OF ARTEMETHER IN TREATMENT OF PNEUMOCYSTIS CARINII IN IMMUNOSUPPRESSED RATS
7
作者 陈雅棠 马良 +2 位作者 梅芹 唐宜 廖晓岗 《Chinese Medical Journal》 SCIE CAS CSCD 1994年第9期35-39,共5页
An immunosuppressed rat model was establisbed by injecting cortisone acetate 25 mg/rat twice a week for 4 weeks and 12.5mg/rat for another 2 weeks subcutaneously.A development of Pneumocystis carinii pneumonia(PCP) wa... An immunosuppressed rat model was establisbed by injecting cortisone acetate 25 mg/rat twice a week for 4 weeks and 12.5mg/rat for another 2 weeks subcutaneously.A development of Pneumocystis carinii pneumonia(PCP) was found at the end of the 6th week in all rats. 展开更多
关键词 AN experimental TRIAL OF ARTEMETHER IN treatment OF PNEUMOCYSTIS CARINII IN IMMUNOSUPPRESSED RATS In
原文传递
Can cannabinoids be a potential therapeutic tool in amyotrophic lateral sclerosis?
8
作者 Sabrina Giacoppo Emanuela Mazzon 《Neural Regeneration Research》 SCIE CAS CSCD 2016年第12期1896-1899,共4页
Amyotrophic lateral sclerosis(ALS) is the most common degenerative disease of the motor neuron system. Over the last years, a growing interest was aimed to discovery new innovative and safer therapeutic approaches i... Amyotrophic lateral sclerosis(ALS) is the most common degenerative disease of the motor neuron system. Over the last years, a growing interest was aimed to discovery new innovative and safer therapeutic approaches in the ALS treatment. In this context, the bioactive compounds of Cannabis sativa have shown antioxidant, anti-inflammatory and neuroprotective effects in preclinical models of central nervous system disease. However, most of the studies proving the ability of cannabinoids in delay disease progression and prolong survival in ALS were performed in animal model, whereas the few clinical trials that investigated cannabinoids-based medicines were focused only on the alleviation of ALS-related symptoms, not on the control of disease progression. The aim of this report was to provide a short but important overview of evidences that are useful to better characterize the efficacy as well as the molecular pathways modulated by cannabinoids. 展开更多
关键词 amyotrophic lateral sclerosis cannabinoids symptomatic ALS treatment experimental ALS model clinical trials mechanisms of neuroprotection
下载PDF
Surgical treatment of hepatocellular carcinoma and related basic research with special reference to recurrence and metastasis 被引量:31
9
作者 汤钊猷 周信达 +14 位作者 林芷英 杨秉辉 马曾辰 叶胜龙 吴志全 樊嘉 刘银坤 刘康达 钦伦秀 田健 孙惠川 贺斌 夏景林 邱双健 周俭 《Chinese Medical Journal》 SCIE CAS CSCD 1999年第10期23-27,共5页
To summarize the progress of surgical treatment of hepatocellular carcinoma (HCC) and related basic research at the Liver Cancer Institute of Shanghai Medical University in the recent years, with special reference to ... To summarize the progress of surgical treatment of hepatocellular carcinoma (HCC) and related basic research at the Liver Cancer Institute of Shanghai Medical University in the recent years, with special reference to recurrence and metastasis Methods Published and unpublished update clinical and experimental data in the above mentioned areas are summarized Results Surgical resection has played an important role in improving prognosis of HCC, the 5 year survival were 63 4% for small HCC resection (n=806), 39 6% for large HCC resection (n=1061), 64 7% for cytoreduction (using hepatic artery cannulation and ligation) and sequential resection of initially unresectable HCC (n=93), 56 0% for cytoreduction using transcatheter arterial chemoembolization (TACE) and followed by resection (n=65), and 22 4% for hepatic resection with removal of tumor thrombi in portal vein (n=103) Unfortunately, the 5 year recurrent rate after curative resection of HCC was up to 61 5%, which was mainly a result of intrahepatic “metastasis” and multicentric origin of HCC Clinically, re resection of subclinical recurrence yielded 56% of 5 year survival (n=202); prevention of recurrence by transcatheter arterial chemoembolization (TACE)+Interferon, or LAK/IL 2 therapy have decreased 3 year recurrent rate from 33% to 11%-18% In experimental aspect, metastatic human HCC model in nude mice (LCI D20) and HCC cell line with metastatic potential (MHCC97) have been established; studies on HCC invasiveness in the molecular level revealed similar results that reported in other solid cancers, and small HCC showed slightly better biological characteristics as compared with large HCC; microvessel density (MVD) that reflecting angiogenesis adversely correlated with 5 year survival of small HCC; experimental interventions using antisense H ras, bispecific antibody, BB94, as well as anti angiogenic agents (TNP470, suramin, CAI, heparin, antisense VEGF, etc ) have been demonstrated to inhibit tumor growth and lung metastasis in nude mice model Conclusions Recurrence and metastasis are the major obstacle to further improve prognosis of HCC, studies should be conducted both in clinical and experimental aspects, “HCC invasiveness” will be the major target to be studied, particularly in the molecular level, and anti angiogenesis will be one of the important approach 展开更多
关键词 hepatocellular carcinoma RECURRENCE METASTASIS metastatic model tumor invasiveness ANGIOGENESIS experimental treatment
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部